Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
01/23/1985 | EP0131868A1 (21-Leucine) human urogastrone, corresponding gene, corresponding recombinant plasmid, transformed cell and process for production thereof |
01/23/1985 | EP0131843A1 Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods |
01/23/1985 | EP0131834A2 Monoclonal antibody having specificity to only one type of an isozyme of human cardiac myosin heavy chain |
01/23/1985 | EP0131816A1 Modified (1-56) beta interferons |
01/23/1985 | EP0131620A1 Genetically transformed plants. |
01/23/1985 | EP0085083B1 Process for the enzymatic preparation of human insulin |
01/22/1985 | US4495288 Method of culturing anchorage dependent cells |
01/22/1985 | US4495287 Process for producing gene products of plasmid having temperature dependent plasmid copy number |
01/22/1985 | US4495176 Phosphopeptides from casein-based material |
01/22/1985 | CA1181282A1 Process for preparing modified protein compositions |
01/17/1985 | WO1985000185A1 Cloning vector, method of constructing such, and method of concentrating and purifying product proteins produced by the cloning vector |
01/16/1985 | EP0131424A2 Improvements in or relating to antibody preparations |
01/16/1985 | EP0131418A1 Proteins, pharmaceutical compositons, genes, vectors, host organisms and processes for their production |
01/16/1985 | EP0131415A2 Monoclonal antibodies, processes for their preparation and methods for their use |
01/16/1985 | EP0131363A1 Polypeptide and protein products, and processes for their production and use |
01/16/1985 | EP0131142A2 Process for recovering a cell wall protein |
01/16/1985 | EP0051646B1 Method of manufacturing collagen slurry |
01/09/1985 | EP0130566A1 Modified (1-28) beta interferons |
01/09/1985 | EP0130565A1 Modified (115-145) beta interferons |
01/09/1985 | EP0130564A1 Modified (80-113) beta interferons |
01/03/1985 | WO1985000043A1 Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
01/02/1985 | EP0130166A1 A recombinant plasmid, a transformant microorganism, a polydeoxy-ribonucleotide segment, a process for producing a biologically active protein, and the protein thus produced |
01/02/1985 | EP0130132A1 Antitumour immunotoxin, pharmaceutical compositions containing it, and its use in vitro |
01/02/1985 | CA1180289A Human proinsulin and preproinsulin genes |
12/27/1984 | EP0129268A2 Improvements in the expression of newly introduced genes in yeast cells |
12/27/1984 | EP0129254A2 Process for the preparation of N-tau-substituted histidine derivatives, the N-tau-substituted histidine derivatives and their use |
12/27/1984 | EP0129073A1 Hybrid DNA synthesis of mature growth hormone releasing factor |
12/27/1984 | CA1179956A Method of producing self-reproducing pancreatic islet-like structures |
12/27/1984 | CA1179953A Processes for inserting dna into eucaryotic cells and for producing proteinaceous materials |
12/25/1984 | US4490289 Homogeneous human interleukin 2 |
12/20/1984 | WO1984004887A1 A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A gamma-INTERFERON CONTAINING PREPARATION |
12/19/1984 | EP0128733A1 Human insulin-like growth factor (IGF) produced from a recombinant host, process, expression vector and recombinant host therefor, and IGF-containing pharmaceutical composition |
12/19/1984 | EP0128567A2 Process for cell fusion |
12/19/1984 | EP0128566A2 Chamber for the treatment of cells in an electric field |
12/19/1984 | EP0128565A2 Process and device for cell fusion |
12/19/1984 | EP0128467A1 Polypeptides having interferon activity |
12/18/1984 | US4489159 Process for preparing esters of human insulin |
12/18/1984 | US4489158 Binding assay for the detection of mycobacteria |
12/12/1984 | EP0127839A2 Method for producing a recombinant baculovirus expression vector |
12/12/1984 | EP0127658A1 A process for preparing ripe proteins from fusion proteins, synthetized in pro- or eukaryotic cells. |
12/11/1984 | US4487835 Plasmid having temperature dependent plasmid copy number |
12/06/1984 | WO1984004756A1 Polypeptide and protein products, and processes for their production and use |
12/06/1984 | WO1984004755A1 Method for controlling the expression of cloned genes |
12/05/1984 | EP0127394A2 Mutant human T cell lines producing immunosuppressive factor and method for obtaining such mutants |
12/05/1984 | EP0127328A2 The use of chromosomal integration to stabilize heterologous genes |
12/05/1984 | EP0127305A1 Human growth hormone, and process for its production, expression vehicles for producing pre HGH and host cells transformed thereby |
12/05/1984 | EP0127304A1 Process for producing heterologous protein in yeast, expression vehicle therefor, and yeast transformed therewith |
12/05/1984 | EP0127173A2 Process for obtaining monoclonal antibodies active against tumour antigens, and medicine containing them |
12/05/1984 | EP0126765A1 Recombinant dna derived antigens of treponema pallidum |
12/04/1984 | US4486538 Detection of malignant tumor cells |
12/04/1984 | CA1178908A1 Method for treating a casein-based raw material containing phosphocaseinates of monovalent cations or derivatives thereof, resulting products and applications thereof |
11/28/1984 | EP0126338A1 Novel process for expressing a foreign gene |
11/28/1984 | EP0126289A2 Process for the purification of microbial protein isolates |
11/28/1984 | EP0126230A1 Novel DNA and use thereof |
11/28/1984 | EP0126166A1 Cloning vectors comprising a restriction site bank and the construction thereof |
11/27/1984 | US4485102 High potency, mycelial-free avoparcin alkyl sulfate complex, and method for the preparation thereof |
11/27/1984 | US4485100 Polypeptides; antishock, antiinflammatory and emphysemia treatment |
11/22/1984 | WO1984004599A1 Monoclonal antibodies against non small cell lung cancer |
11/22/1984 | WO1984004538A1 Improvements in the expression of newly introduced genes in yeast cells |
11/22/1984 | WO1984004458A1 Monoclonal antibodies reactive with endotoxin core |
11/22/1984 | WO1984003712A3 Multichain polypeptides or proteins and processes for their production |
11/21/1984 | EP0125928A2 Monoclonal antibodies against non small cell lung cancer |
11/14/1984 | EP0125023A1 Recombinant immunoglobulin preparations, methods for their preparation, DNA sequences, expression vectors and recombinant host cells therefor |
11/14/1984 | EP0124874A2 Novel vectors for interferon expression |
11/14/1984 | EP0124787A2 Nitrogen source for organisms |
11/14/1984 | EP0124717A2 Human monoclonal antibodies to cancer cells |
11/14/1984 | EP0124613A1 Novel plasminogen activator derived from human kidneys, process for its preparation, and thrombolytic drug containing the same |
11/13/1984 | US4482543 Biologically active substance, process for preparing the substance and immunoactive composition |
11/13/1984 | CA1177764A1 Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins |
11/13/1984 | CA1177753A1 Method of growing hepatitis b surface antigen background of the invention |
11/08/1984 | WO1984004330A1 Secretion of exogenous polypeptides from yeast |
11/07/1984 | EP0124374A1 Production of protein A |
11/07/1984 | EP0124301A1 Human hybrid cell lines, production and use thereof |
11/07/1984 | EP0123945A1 New factor VIII coagulant polypeptides |
11/07/1984 | EP0123811A2 The use of the GAL 1 yeast promoter |
11/06/1984 | US4481137 Antitumor agents from cell cultures |
11/06/1984 | CA1177429A2 Process for enzymatic production of peptides |
11/06/1984 | CA1177428A1 Process for the preparation of a peptide from cultures of a trematode and use of this peptide as a drug |
10/31/1984 | EP0123294A1 Yeast cell transformation vectors |
10/31/1984 | EP0123289A2 A-factor and its processing signals |
10/31/1984 | EP0123228A2 Hybrid DNA synthesis of mature insulin-like growth factors |
10/30/1984 | US4480038 Distillation |
10/25/1984 | WO1984004172A1 Monoclonal antibodies to human immune interferon |
10/25/1984 | WO1984004108A1 Novel immunoglobulin-coding dna |
10/24/1984 | EP0122841A1 Anti-human cytomegalovirus-monoclonal antibodies, hybridomas secreting those antibodies and polypeptides carrying a sequential antigenic determinant of human cytomegalovirus |
10/24/1984 | EP0122814A2 A method of cotransformation, cotransformed mouse cells producing at their surface human class II antigens and the use of those cells to generate mouse hybridomas that produce monoclonal antibodies to those antigens |
10/24/1984 | EP0122628A2 Monoclonal antibodies to human immune interferon |
10/24/1984 | EP0122478A2 A method for the preparation of monoclonal antibody with specificity for crosslinked fibrin derivatives and an assay procedure using said antibody |
10/23/1984 | US4478831 Bactericides |
10/17/1984 | EP0122080A1 A process for the production of a protein |
10/17/1984 | EP0121884A2 Hybrid DNA synthesis of insulin |
10/17/1984 | EP0121788A2 Process for the preparation of the alpha-amylase inactivator tendamistat in a crystalline form |
10/16/1984 | US4477576 Qualitative analysis; solid matrix linked to protein-antigen-antibody-enzyme |
10/16/1984 | US4477567 Continuous bovine beta cell line |
10/11/1984 | WO1984003887A1 Novel physiologically active proteinaceous substance |
10/10/1984 | EP0121400A2 Process for preparing and isolating living hybrid cells |
10/10/1984 | EP0121338A1 Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, DNA sequence encoding it, vectors containing the sequence and host cells transformed thereby |
10/10/1984 | EP0121157A1 Novel human interferon-gamma polypeptide |
10/10/1984 | EP0121107A1 Process for the conditioning of microbial cell masses |
10/09/1984 | US4476049 With protease inhibitor |